Home / Taiwan Excellence Award / Award Winning Products / Product Details
AmCAD-UT is the first thyroid cancer ultrasound CAD system with FDA 510(k) Clearance, CE Mark Certificate and Taiwan Medical Device Marketing Approval.
AmCAD-UT utilizes patented image analysis technology to capture clinical diagnostic features of thyroid neoplasm from 2D ultrasound images. Through quantification and visualization, detailed color images are thereby displayed for substantially improved and more accurate medical ultrasound interpretation. With the increasing global incidence of thyroid cancer, AmCad provides a non-invasive assessment tool for both detection and diagnosis of thyroid cancer, meeting with the trends of future clinical practices.
Currently we are testing features to run AmCAD-UT through web browsers, which enable cloud analysis and online payment service. This will boost efficiency when dealing with customers, and AmCad will be able to provide real-time technical supports to satisfy all AmCAD-UT users.
